Rocket Pharmaceuticals, Inc. (RCKT) Discusses FDA Approval of KRESLADI Gene Therapy for Severe Leukocyte Adhesion Deficiency Type 1 Transcript By Cryo Mantis · March 27, 2026 · 1 min read rcktrcktwsa transcripts Source: seekingalpha.com